Literature DB >> 6115670

Alpha-chain domain of fibrinogen controls generation of fibrinoligase (coagulation factor XIIIa). Calcium ion regulatory aspects.

R B Credo, C G Curtis, L Lorand.   

Abstract

Fibrinogen (approximately 10(-5) M) labilizes heterologous interactions within the thrombin-modified factor XIII zymogen (i.e., XIII' = a2'b2) so that, in the time frame (ca. 10 min) of normal clotting in plasma (37 degrees C, mu = 0.15, pH 7.5), 1.5 mM Ca2+ is sufficient to cause the release of the noncatalytic b subunits and also the unmasking of 1 equiv of iodo[1-14C]acetamide-titratable group per catalytic a subunit. Under similar conditions, but in the absence of fibrinogen, approximately 10 mM Ca2+ would be needed to achieve the same effect. Thus, by promoting the conversion of XIII' to XIIIa (i.e., a2'b2 leads to a2* + b2), fibrinogen functions as a physiologically important Ca2+-modulator protein. Total plasmin digests of fibrinogen display the regulatory phenomenon nearly as well as the parent protein. In an attempt to identify the structural domain on the fibrinogen which is responsible for this novel function of the molecule, it was found that two overlapping fragments derived from the midsections of the alpha chains, either by CNBr cleavage (residues 243-476) or by plasmin digestion (residues 242-424), are active.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6115670     DOI: 10.1021/bi00516a016

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  Transglutaminase-catalyzed crosslinking of the Aalpha and gamma constituent chains in fibrinogen.

Authors:  S N Murthy; J H Wilson; T J Lukas; Y Veklich; J W Weisel; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

Authors:  Kevin R Siebenlist; Michael W Mosesson; Irene Hernandez; Leslie A Bush; Enrico Di Cera; John R Shainoff; James P Di Orio; Laurie Stojanovic
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

3.  Identification of an ordered compact structure within the recombinant bovine fibrinogen alphaC-domain fragment by NMR.

Authors:  Robert A Burton; Galina Tsurupa; Leonid Medved; Nico Tjandra
Journal:  Biochemistry       Date:  2006-02-21       Impact factor: 3.162

4.  NMR solution structure, stability, and interaction of the recombinant bovine fibrinogen alphaC-domain fragment.

Authors:  Robert A Burton; Galina Tsurupa; Roy R Hantgan; Nico Tjandra; Leonid Medved
Journal:  Biochemistry       Date:  2007-06-23       Impact factor: 3.162

5.  Fibrinogen cleavage by the Streptococcus pyogenes extracellular cysteine protease and generation of antibodies that inhibit enzyme proteolytic activity.

Authors:  Y V Matsuka; S Pillai; S Gubba; J M Musser; S B Olmsted
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 6.  Newly-Recognized Roles of Factor XIII in Thrombosis.

Authors:  James R Byrnes; Alisa S Wolberg
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

7.  Impaired factor XIII activation in patients with congenital afibrinogenemia.

Authors:  Françoise Bridey; Claude Négrier; Cedric Duval; Robert Ariëns; Philippe de Moerloose; Alessandro Casini
Journal:  Haematologica       Date:  2018-09-27       Impact factor: 9.941

Review 8.  Transglutaminases.

Authors:  L Lorand; S M Conrad
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

9.  Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366).

Authors:  Kelly Njine Mouapi; Lucille J Wagner; Chad A Stephens; Mohammed M Hindi; Daniel W Wilkey; Michael L Merchant; Muriel C Maurer
Journal:  Thromb Haemost       Date:  2019-05-05       Impact factor: 5.249

10.  Identification of the Staphylococcus aureus MSCRAMM clumping factor B (ClfB) binding site in the alphaC-domain of human fibrinogen.

Authors:  Evelyn J Walsh; Helen Miajlovic; Oleg V Gorkun; Timothy J Foster
Journal:  Microbiology (Reading)       Date:  2008-02       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.